Showing results (331-340 of 448) with videos related to

Sort By:
Pageof 45
Kidney International|June 1, 1979
Microvascular and clinical effects of altered peritoneal dialysis solutionsF N Miller, K D Nolph, P D Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
A Phase II trial of flavopiridol (NSC #649890) in patients with previously untreated metastatic androgen-independent prostate cancerGlenn Liu, David R Gandara, Primo N Lara, et al.
International Journal of Clinical Oncology|March 25, 2011
A phase II trial of gefitinib and pegylated IFNα in previously treated renal cell carcinomaDerek Shek, Jeff Longmate, David I Quinn, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1995
A new approach to optimizing urea clearances in hemodialysis and continuous ambulatory peritoneal dialysisK D Nolph, P Keshaviah, P Emerson, et al.
Minerva Anestesiologica|September 16, 2014
Ondansetron attenuates the decrease in blood pressure due to spinal anesthesia in the elderly: a double blind, placebo-controlled studyR Owczuk, W Wenski, P Twardowski, et al.
Optics Express|April 1, 2009
Polarized light in coastal waters: hyperspectral and multiangular analysisAlberto Tonizzo, Jing Zhou, Alexander Gilerson, et al.
Cancers|February 11, 2023
Mechanism-Driven and Clinically Focused Development of Botanical Foods as Multitarget Anticancer Medicine: Collective Perspectives and Insights from Preclinical Studies, IND Applications and Early-Phase Clinical TrialsXiaoqiang Wang, Yin S Chan, Kelly Wong, et al.
International Journal of Environmental Research and Public Health|March 6, 2021
Qualitative and Quantitative Assessment of Buckwheat Husks as a Material for Use in Therapeutic MattressesAgnieszka Nawirska-Olszańska, Adam Figiel, Elżbieta Pląskowska, et al.
Cancer|December 22, 2017
Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration-resistant prostate cancer (CRPC)Sumanta Kumar Pal, Jaymala Patel, Miaoling He, et al.
Cancer|May 20, 2015
A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid-derived suppressor cells for Agaricus bisporus-induced prostate-specific antigen responsesPrzemyslaw Twardowski, Noriko Kanaya, Paul Frankel, et al.
Pageof 45